Cuong do

Cuong Do is an accomplished executive in the biotechnology and healthcare sectors with significant experience in founding and leading innovative companies. Currently serving as the President and Chief Executive Officer of BioVie Inc., Cuong Do focuses on developing therapies for Alzheimer's Disease, Parkinson's Disease, and Ascites since May 2021. As the Founder and Chairman of M6P Therapeutics, Cuong Do is advancing targeted recombinant enzyme and gene therapies for lysosomal storage disorders. Additionally, Cuong Do established Perceptivus, LLC, a consulting and investment firm, and Identifor, Inc., an AI-driven startup aimed at helping parents assess their children's abilities. Former roles include high-level positions at Samsung, Merck, Callidus Biopharma, Tyco Electronics, Lenovo, and McKinsey & Company. Cuong Do holds an MBA from The Tuck School of Business at Dartmouth and a BA in Biochemistry and Economics from Dartmouth College.